|
|
Article: Competition Bureau Requires Significant Divestitures in Merger of Pfizer and Wyeth.
- Article from:
- Marketwire Canada
- Article date:
- October 14, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
OTTAWA, ONTARIO, Oct 14, 2009 (Marketwire via COMTEX) -- The Competition Bureau announced today that it has reached an agreement with Pfizer Inc. and Wyeth requiring, among other things, that the companies divest a significant number of animal health products to resolve competition concerns with respect to their proposed merger.
Under the terms of an agreement with the companies, Pfizer and Wyeth will divest certain animal pharmaceutical and vaccine products to Boehringer Ingelheim Vetmedica, Inc. Additionally, Pfizer will amend the terms of its existing arrangement with Paladin Labs Inc. governing the distribution, marketing and sale of Pfizer's human ...